CapitalBio seeks cooperation with Arab states
A subsidiary of CapitalBio Corporation, an affiliated company of Tsinghua Holdings, established a cooperative relationship with the United Arab Emirates-Dubai sub center of the China-Arab States Technology Transfer Center (CASTTC) at the Middle East Laboratory Conference and Exhibition 2017 in Dubai.
Representatives of CapitalBio and the CASTTC's United Arab Emirates-Dubai sub center discuss potential cooperation opportunities at MedLab 2017, a medical and scientific instruments exhibition in Dubai.
Representatives of the United Arab Emirates-Dubai sub center showed great interest in CapitalBio's chemiluminescence platform, flow cytometry system and miRNA cancer early diagnosis system. They expressed their eagerness to import the three technologies to the Arab states.
Representatives of CapitalBio and the CASTTC's United Arab Emirates-Dubai sub center pose for a photo at MedLab 2017.
China established the CASTTC in Northwest China's Ningxia Hui autonomous region to facilitate collaborative innovation with Arab countries after President Xi Jinping delivered a keynote speech at the opening ceremony of the Sixth Ministerial Conference of the China-Arab States Cooperation Forum in Beijing in 2014.